Lansoprazole Capsule, Delayed Release
Product Images NDC 51407-324

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 51407-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-324-01lb.jpg (51407 324 01lb)

This is a description of a medication called Lansoprazole, which is contained in delayed-release capsules. The medication is produced by GSMS Incorporated and packaged in the United States. Each capsule contains 30mg of Lansoprazole. Customers are instructed to follow the usage details in the package insert and to store the medication at a controlled room temperature. Additionally, pharmacists are instructed to provide a Medication Guide to each patient alongside the drug.*

FDA Label Image

Figure-1.jpg (Figure 1)

This is a chart showing the mean severity of day heartburn by study day for evaluable patients. There are three groups being compared: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The severity is measured on a scale of 0 (none) to 3 (severe). The chart shows the data for study days 18, 20, and 25.*

FDA Label Image

Figure-2.jpg (Figure 2)

This text represents a table showing the mean severity of night heartburn by study day for evaluable patients who received different treatments. The severity of heartburn was measured using a scale where 3 indicates severe heartburn, 2 indicates moderate heartburn, 1 is unclear, and 0 indicates no heartburn. The table includes data for three treatment groups consisting of a placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The table reports data for 18 days from the start of the treatment, and it shows the percentage of patients who experience heartburn of different severity levels on different days.*

FDA Label Image

Formula-structure.jpg (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.